Thi Quynh Nguyen, PHARMD
Ambulatory Care · Milpitas
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Thi Quynh Nguyen’s office at (408) 945-2900 to ask if they take your plan before you enroll.
California Medical Board record
Licence G76661 · Cancelled
Licence status: Cancelled · since 1993 · Loma Linda University School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$157,624
Pharmacies billed $157,624 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 821) in 2024. At or below the middle of the specialty; the typical pharmacist clinician is at 0%.
400 generic and 313 brand-name prescriptions · $157,624 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 94 | $69,533 | $740 |
| Victoza 2-Pak | 15 | $9,599 | $640 |
| Victoza 3-Pak | 12 | $9,105 | $759 |
| Humulin N | 50 | $8,395 | $168 |
| Humulin 70-30 | 27 | $7,491 | $277 |
See all 20 drugs
| Ozempic | 94 | $69,533 | $740 |
| Victoza 2-Pak | 15 | $9,599 | $640 |
| Victoza 3-Pak | 12 | $9,105 | $759 |
| Humulin N | 50 | $8,395 | $168 |
| Humulin 70-30 | 27 | $7,491 | $277 |
| Insulin Glargine-Yfgn | 28 | $3,755 | $134 |
| Humulin 70/30 Kwikpen | 11 | $3,527 | $321 |
| Humulin R | 23 | $3,502 | $152 |
| Glipizide Er | 48 | $1,325 | $28 |
| Atorvastatin | 86 | $1,033 | $12 |
| Metformin Hcl Er | 93 | $975 | $10 |
| Veo Insulin | 26 | $695 | $27 |
| Ultra-Fine Nano Pen Needle | 27 | $677 | $25 |
| Glipizide | 51 | $628 | $12 |
| Veo Insulin | 24 | $573 | $24 |
| Metformin | 34 | $412 | $12 |
| Ultra-Fine Mini Pen Needle | 11 | $327 | $30 |
| Veo Insulin | 17 | $324 | $19 |
| Simvastatin | 16 | $187 | $12 |
| Pioglitazone | 13 | $147 | $11 |
Year by year
| 2024 | 821 | 208 | 0% (0) | 38% | $157,624 |
| 2023 | 1,055 | 189 | 0% (0) | 31% | $182,565 |
| 2022 | 745 | 171 | 0% (0) | 24% | $79,388 |
| 2021 | 445 | 241 | 10% (43) | 18% | $29,606 |
| 2020 | 586 | 434 | 9% (50) | 3% | $10,832 |
| 2019 | 768 | 551 | 0% (0) | 2% | $11,063 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Ozempic | 37 | $34,450 | $931 |
| Jardiance | 38 | $28,150 | $741 |
| Victoza 2-Pak | 17 | $28,074 | $1,651 |
| Humulin N | 88 | $14,916 | $169 |
| Humulin 70-30 | 43 | $9,105 | $212 |
| Humulin 70/30 Kwikpen | 19 | $8,079 | $425 |
| Humulin R | 40 | $4,900 | $123 |
| Humulin N Kwikpen | 15 | $2,050 | $137 |
| Atorvastatin | 112 | $1,476 | $13 |
| Glipizide | 96 | $1,356 | $14 |
| Pioglitazone | 61 | $1,301 | $21 |
| Metformin Hcl Er | 119 | $1,223 | $10 |
| Glipizide Er | 34 | $1,138 | $33 |
| Metformin | 71 | $877 | $12 |
| Ultra-Fine Nano Pen Needle | 33 | $858 | $26 |
| Veo Insulin | 31 | $735 | $24 |
| Veo Insulin | 34 | $731 | $22 |
| Veo Insulin | 19 | $366 | $19 |
| Rosuvastatin | 22 | $319 | $14 |
| Simvastatin | 25 | $292 | $12 |
| Losartan | 16 | $197 | $12 |
| Lovastatin | 13 | $165 | $13 |
2022: 19 drugs
| Humulin N | 74 | $13,356 | $180 |
| Jardiance | 17 | $12,084 | $711 |
| Humulin 70/30 Kwikpen | 11 | $3,709 | $337 |
| Humulin 70-30 | 14 | $3,201 | $229 |
| Humulin R | 23 | $3,015 | $131 |
| Glipizide | 105 | $1,386 | $13 |
| Glipizide Er | 30 | $1,073 | $36 |
| Atorvastatin | 81 | $1,070 | $13 |
| Pioglitazone | 38 | $992 | $26 |
| Ultra-Fine Nano Pen Needle | 23 | $827 | $36 |
| Metformin | 65 | $781 | $12 |
| Metformin Hcl Er | 73 | $745 | $10 |
| Veo Insulin | 32 | $691 | $22 |
| Veo Insulin | 24 | $566 | $24 |
| Rosuvastatin | 16 | $253 | $16 |
| Veo Insulin | 12 | $216 | $18 |
| Simvastatin | 17 | $198 | $12 |
| Losartan | 15 | $165 | $11 |
| Lovastatin | 11 | $142 | $13 |
2021: 14 drugs
| Humulin N | 44 | $8,513 | $193 |
| Humulin R | 12 | $1,667 | $139 |
| Hydrocodone-Acetaminophen | 31 | $635 | $20 |
| Glipizide | 42 | $580 | $14 |
| Hydralazine | 14 | $474 | $34 |
| Metformin Hcl Er | 39 | $392 | $10 |
| Veo Insulin | 14 | $325 | $23 |
| Amlodipine Besylate | 30 | $302 | $10 |
| Veo Insulin | 12 | $298 | $25 |
| Atorvastatin | 22 | $271 | $12 |
| Atenolol | 23 | $242 | $11 |
| Metformin | 19 | $223 | $12 |
| Alendronate | 17 | $177 | $10 |
| Pioglitazone | 12 | $164 | $14 |
2020: 13 drugs
| Amlodipine Besylate | 110 | $1,303 | $12 |
| Levothyroxine | 43 | $1,132 | $26 |
| Hydralazine | 41 | $613 | $15 |
| Losartan | 48 | $598 | $12 |
| Alendronate | 53 | $583 | $11 |
| Hydrocodone-Acetaminophen | 24 | $489 | $20 |
| Atenolol | 34 | $387 | $11 |
| Hydrochlorothiazide | 33 | $331 | $10 |
| Lisinopril | 29 | $331 | $11 |
| Metoprolol | 17 | $298 | $18 |
| Allopurinol | 11 | $214 | $19 |
| Lisinopril-Hydrochlorothiazide | 20 | $195 | $10 |
| Metoprolol | 16 | $192 | $12 |
2019: 13 drugs
| Amlodipine Besylate | 168 | $1,779 | $11 |
| Hydralazine | 72 | $1,017 | $14 |
| Losartan | 70 | $834 | $12 |
| Levothyroxine | 30 | $785 | $26 |
| Lisinopril | 73 | $734 | $10 |
| Losartan-Hydrochlorothiazide | 42 | $605 | $14 |
| Alendronate | 50 | $544 | $11 |
| Atenolol | 46 | $528 | $11 |
| Atorvastatin | 22 | $481 | $22 |
| Lisinopril-Hydrochlorothiazide | 43 | $469 | $11 |
| Metoprolol | 15 | $437 | $29 |
| Hydrochlorothiazide | 44 | $395 | $9 |
| Metoprolol | 17 | $183 | $11 |
Professional record
- NPI
- 1841786399
- Licence
- CA 76661California G76661: Cancelled
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 1835P2201X (1835P2201X)
- Mailing address
- 770 E Calaveras Blvd, Milpitas, CA, 95035
- NPI first listed
- 2018-07-09
- NPI last updated
- 2024-10-08
- NPI record certified
- 2024-10-08
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.